EFEKTIFITAS TERAPI ADVERSE DRUG REACTION ANEMIA PADA PASIEN KANKER OVARIUM YANG DIINDUKSI KEMOTERAPI
Abstract
Keywords
Full Text:
PDFReferences
Liu, X., Chan, D., & Ngan, H. Mechanisms of Chemoresistance in Human Ovarian Cancer at a Glance. Gynecology & Obstetrics. 2012; 2(3): 1000e104. https://doi.org/10.4172/2161-0932.1000e104
Rani, G., Aruna, T. B. P., Arumugam., Meenakshi, B., & J, E. R. Study Of Adverse Drug Reactions To Chemotherapeutic Agents. 2017; 4(8): 831–836.
Schartz, S. N., & Weber, R. J. Adverse drug reactions. 2015; 229–267. Retrieved from https://www.accp.com/docs/bookstore/psap/2015B2. SampleChapter.pdf
Guidelines NCCN. (2014). Cancer- and Induced Anemia.
Badan Pengawas Obat dan Makanan Republik Indonesia. Pedoman Monioring Efek Samping Obat (MESO) Bagi Tenaga Kesehatan. 2012; 8–12. https://doi.org/10.1007/s13546-011-0393-1
BC Cancer Agency. Carboplatin. 2014; 1–9. Retrieved from http://www.bccancer.bc.ca/NR/rdonlyres/31E5B9AC-782D-4942-BC31-CA2B0012F3CA/67832/Carboplatinmonograph_1Jan2014.pdf
Guidelines NCCN. Ovarian Cancer. 2017; 1–100. https://doi.org/10.1007/978-1-62703-547-7
Xu, L., Page, J. H., Cannavale, K., Sattayapiwat, O., & Rodriguez, R. Incidence of anemia in patients diagnosed with solid tumors receiving chemotherapy 2010 – 2013. 2016; 61–71.
BC-Cancer Agency. Paclitaxel. BC Cancer Drug Manual©. 2018; 1–10. Retrieved from http://www.bccancer.bc.ca/drug-database-site/Drug Index/Paclitaxel_monograph.pdf
Madeddu, C., Gramignano, G., Astara, G., Demontis, R., Sanna, E., Atzeni, V., & Macciò, A. Pathogenesis and Treatment Options of Cancer Related Anemia : Perspective for a Targeted Mechanism-Based Approach. 2018; 1–20. https://doi.org/10.3389/fphys.2018.01294
Guidelines NCCN. Cancer and Induced Anemia. 2018.
DOI: https://doi.org/10.36409/jika.v7i2.179
Refbacks
- There are currently no refbacks.

This work is licensed under a Creative Commons Attribution 4.0 International License.

This work is licensed under a Creative Commons Attribution 4.0 International License.